Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
Costa S, Mondini M, Caneparo V, Afeltra A, Airò P, Bellisai F, Faggioli P, Gerli R, Lotzniker M, Meroni PL, Morozzi G, Radice A, Riccieri V, Scarsi M, Sebastiani GD, Sinico RA, Tincani A, Gariglio M, Landolfo S. Costa S, et al. Among authors: faggioli p. Rheumatology (Oxford). 2011 Apr;50(4):674-81. doi: 10.1093/rheumatology/keq372. Epub 2010 Dec 6. Rheumatology (Oxford). 2011. PMID: 21134960
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study.
Taraborelli M, Ramoni V, Brucato A, Airò P, Bajocchi G, Bellisai F, Biasi D, Blagojevic J, Canti V, Caporali R, Caramaschi P, Chiarolanza I, Codullo V, Cozzi F, Cuomo G, Cutolo M, De Santis M, De Vita S, Di Poi E, Doria A, Faggioli P, Favaro M, Ferraccioli G, Ferri C, Foti R, Gerosa A, Gerosa M, Giacuzzo S, Giani L, Giuggioli D, Imazio M, Iudici M, Iuliano A, Leonardi R, Limonta M, Lojacono A, Lubatti C, Matucci-Cerinic M, Mazzone A, Meroni M, Meroni PL, Mosca M, Motta M, Muscarà M, Nava S, Padovan M, Pagani G, Paolazzi G, Peccatori S, Ravagnani V, Riccieri V, Rosato E, Rovere-Querini P, Salsano F, Santaniello A, Scorza R, Tani C, Valentini G, Valesini G, Vanoli M, Vigone B, Zeni S, Tincani A; IMPRESS Investigators. Taraborelli M, et al. Among authors: faggioli p. Arthritis Rheum. 2012 Jun;64(6):1970-7. doi: 10.1002/art.34350. Epub 2011 Dec 28. Arthritis Rheum. 2012. PMID: 22213060 Free article.
Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology.
Zanetti A, Carrara G, Landolfi G, Rozza D, Chighizola CB, Alunno A, Andreoli L, Caporali R, Gerli R, Sebastiani GD, Valesini G, Sinigaglia L, Raffeiner B, Lomater C, Caprioli M, Fredi M, Romeo N, Cuomo G, Vadacca M, Scirè CA; CONTROL-19 study by the Italian Society for Rheumatology. Zanetti A, et al. Clin Exp Rheumatol. 2022 Nov;40(11):2038-2043. doi: 10.55563/clinexprheumatol/fmyozh. Epub 2022 Mar 8. Clin Exp Rheumatol. 2022. PMID: 35260224 Free article.
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
Gatto M, Saccon F, Zen M, Regola F, Fredi M, Andreoli L, Tincani A, Urban ML, Emmi G, Ceccarelli F, Conti F, Bortoluzzi A, Govoni M, Tani C, Mosca M, Ubiali T, Gerosa M, Bozzolo E, Canti V, Cardinaletti P, Gabrielli A, Tanti G, Gremese E, De Marchi G, De Vita S, Fasano S, Ciccia F, Pazzola G, Salvarani C, Negrini S, Puppo F, Di Matteo A, De Angelis R, Orsolini G, Rossini M, Faggioli P, Laria A, Piga M, Mathieu A, Scarpato S, Rossi FW, de Paulis A, Brunetta E, Ceribelli A, Selmi C, Prete M, Racanelli V, Vacca A, Bartoloni E, Gerli R, Larosa M, Iaccarino L, Doria A. Gatto M, et al. Among authors: faggioli p. Arthritis Rheumatol. 2020 Aug;72(8):1314-1324. doi: 10.1002/art.41253. Epub 2020 Jun 12. Arthritis Rheumatol. 2020. PMID: 32275125
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
Gatto M, Saccon F, Andreoli L, Bartoloni E, Benvenuti F, Bortoluzzi A, Bozzolo E, Brunetta E, Canti V, Cardinaletti P, Ceccarelli F, Ciccia F, Conti F, De Marchi G, de Paulis A, De Vita S, Emmi G, Faggioli P, Fasano S, Fredi M, Gabrielli A, Gasparotto M, Gerli R, Gerosa M, Govoni M, Gremese E, Laria A, Larosa M, Mosca M, Orsolini G, Pazzola G, Petricca L, Ramirez GA, Regola F, Rossi FW, Rossini M, Salvarani C, Scarpato S, Tani C, Tincani A, Ubiali T, Urban ML, Zen M, Doria A, Iaccarino L. Gatto M, et al. Among authors: faggioli p. J Autoimmun. 2021 Nov;124:102729. doi: 10.1016/j.jaut.2021.102729. Epub 2021 Sep 30. J Autoimmun. 2021. PMID: 34600347
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.
Fraticelli P, Gabrielli B, Pomponio G, Valentini G, Bosello S, Riboldi P, Gerosa M, Faggioli P, Giacomelli R, Del Papa N, Gerli R, Lunardi C, Bombardieri S, Malorni W, Corvetta A, Moroncini G, Gabrielli A; Imatinib in Scleroderma Italian Study Group. Fraticelli P, et al. Among authors: faggioli p. Arthritis Res Ther. 2014 Jul 8;16(4):R144. doi: 10.1186/ar4606. Arthritis Res Ther. 2014. PMID: 25007944 Free PMC article. Clinical Trial.
38 results